文献速递临床试验与 GCP新药、器械与细胞基因治疗研发

对乙酰氨基酚联合布洛芬对全髋关节置换术后24小时吗啡用量的影响:PANSAID随机临床试验

Effect of Combination of Paracetamol (Acetaminophen) and Ibuprofen vs Either Alone on Patient-Controlled Morphine Consumption in the First 24 Hours After Total Hip Arthroplasty: The PANSAID Randomized Clinical Trial.
PubMed 文献 · JAMA · 2019-01-01

该随机、盲法、安慰剂对照的四组试验在6家丹麦医院纳入556例全髋关节置换术患者,比较对乙酰氨基酚联合布洛芬与单药及半剂量联合的术后镇痛效果。结果显示对乙酰氨基酚联合布洛芬较对乙酰氨基酚单药显著减少24小时吗啡用量,但联合方案较布洛芬单药无临床重要改善。

要点

  • 对乙酰氨基酚联合布洛芬较对乙酰氨基酚单药减少24小时吗啡用量16 mg。
  • 联合方案较布洛芬单药的吗啡用量差异无统计学意义。
  • 接受布洛芬组严重不良事件比例15%,对乙酰氨基酚单药组11%,差异无统计学意义。

核心结论

  • 全髋关节置换术后,对乙酰氨基酚联合布洛芬较对乙酰氨基酚单药显著减少24小时吗啡用量,但联合方案较布洛芬单药无临床重要改善。
  • 接受布洛芬组与对乙酰氨基酚单药组的严重不良事件风险差异无统计学意义。

研究设计与样本

  • 随机、盲法、安慰剂对照的四组试验,在6家丹麦医院进行,随访90天。
  • 纳入556例全髋关节置换术患者,随机分为对乙酰氨基酚1000 mg联合布洛芬400 mg组(n=136)、对乙酰氨基酚1000 mg联合安慰剂组(n=142)、布洛芬400 mg联合安慰剂组(n=141)、半剂量对乙酰氨基酚500 mg联合布洛芬200 mg组(n=140)。
  • 干预为术后24小时内每6小时口服一次,术前1小时开始。

主要发现

  • 24小时吗啡消耗中位数:联合组20 mg(99.6% CI, 0-148),对乙酰氨基酚单药组36 mg(99.6% CI, 0-166),布洛芬单药组26 mg(99.6% CI, 2-139),半剂量联合组28 mg(99.6% CI, 2-145)。
  • 联合组与对乙酰氨基酚单药组吗啡消耗中位差值为16 mg(99.6% CI, 6.5 to 24; P < .001)。
  • 对乙酰氨基酚单药组与半剂量联合组中位差值为8 mg(99.6% CI, -1 to 14; P = .001)。
  • 联合组与布洛芬单药组中位差值为6 mg(99.6% CI, -2 to 16; P = .002)。
  • 联合组与半剂量联合组(8 mg [99.6% CI, -2 to 16]; P = .005)、对乙酰氨基酚单药组与布洛芬单药组(10 mg [99.6% CI, -2 to 16]; P = .004)在多重比较校正后差异无统计学意义。

关键数值与推荐

  • 主要结局之一为24小时患者自控镇痛吗啡消耗量,多重比较校正显著性阈值P < .0042,最小临床重要差异10 mg。
  • 另一主要结局为90天内发生1个及以上严重不良事件的比例,多重比较校正显著性阈值P < .025。

临床怎么用

  • 全髋关节置换术后早期口服镇痛,布洛芬单药可能是合理选择。
  • 对乙酰氨基酚联合布洛芬较对乙酰氨基酚单药可减少吗啡用量,但较布洛芬单药无临床重要优势。

局限性

  • 原文未报告局限性内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Multimodal postoperative analgesia is widely used but lacks evidence of benefit. OBJECTIVE: Investigate beneficial and harmful effects of 4 nonopioid analgesics regimens. DESIGN, SETTING, AND PARTICIPANTS: Randomized, blinded, placebo-controlled, 4-group trial in 6 Danish hospitals with 90-day follow-up that included 556 patients undergoing total hip arthroplasty (THA) from December 2015 to October 2017. Final date of follow-up was January 1, 2018. INTERVENTIONS: Participants were randomized to receive paracetamol (acetaminophen) 1000 mg plus ibuprofen 400 mg (n = 136; PCM + IBU), paracetamol 1000 mg plus matched placebo (n = 142; PCM), ibuprofen 400 mg plus matched placebo (n = 141; IBU), or half-strength paracetamol 500 mg plus ibuprofen 200 mg (n = 140; HS-PCM + IBU) orally every 6 hours for 24 hours postoperatively, starting 1 hour before surgery. MAIN OUTCOMES AND MEASURES: Two co-primary outcomes: 24-hour morphine consumption using patient-controlled analgesia in pairwise comparisons between the 4 groups (multiplicity-adjusted thresholds for statistical significance, P < .0042; minimal clinically important difference, 10 mg), and proportion of patients with 1 or more serious adverse events (SAEs) within 90 days (multiplicity-adjusted thresholds for statistical significance, P < .025). RESULTS: Among 559 randomized participants (mean age, 67 years; 277 [50%] women), 556 (99.5%) completed the trial and were included in the analysis. Median 24-hour morphine consumption was 20 mg (99.6% CI, 0-148) in the PCM + IBU group, 36 mg (99.6% CI, 0-166) for PCM alone, 26 mg (99.6% CI, 2-139) for IBU alone, and 28 mg (99.6% CI, 2-145) for HS-PCM + IBU. The median difference in morphine consumption between the PCM + IBU group vs PCM alone was 16 mg (99.6% CI, 6.5 to 24; P < .001); for the PCM-alone group vs HS-PCM + IBU, 8 mg (99.6% CI, -1 to 14; P = .001); and for the PCM + IBU group vs IBU alone, 6 mg (99.6% CI, -2 to 16; P = .002). The difference in morphine consumption was not statistically significant for the PCM + IBU group vs HS-PCM + IBU (8 mg [99.6% CI, -2 to 16]; P = .005) or for the PCM-alone group vs IBU alone (10 mg [99.6% CI, -2 to 16]; P = .004) after adjustment for multiple comparisons and 2 co-primary outcomes. There was no significant difference between the IBU-alone group vs HS-PCM + IBU (2 mg [99.6% CI, -10 to 7]; P = .81). The proportion of patients with SAEs in groups receiving IBU was 15%, and in the PCM-alone group, was 11%. The relative risk of SAE was 1.44 (97.5% CI, 0.79 to 2.64; P = .18). CONCLUSIONS AND RELEVANCE: Among patients undergoing THA, paracetamol plus ibuprofen significantly reduced morphine consumption compared with paracetamol alone in the first 24 hours after surgery; there was no statistically significant increase in SAEs in the pooled groups receiving ibuprofen alone vs with paracetamol alone. However, the combination did not result in a clinically important improvement over ibuprofen alone, suggesting that ibuprofen alone may be a reasonable option for early postoperative oral analgesia. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02571361.

来源:JAMA,查看原文。版权归原作者所有。

引用

  1. Thybo KH, Hägi-Pedersen D, Dahl JB, et al. Effect of Combination of Paracetamol (Acetaminophen) and Ibuprofen vs Either Alone on Patient-Controlled Morphine Consumption in the First 24 Hours After Total Hip Arthroplasty: The PANSAID Randomized Clinical Trial. JAMA. 2019. PMID: 30747964. doi:10.1001/jama.2018.22039

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。